Pancreatic Cancer in the Very Elderly Patient: Challenges and Solutions
DOI:
https://doi.org/10.17140/SROJ-3-116Keywords:
Pancreatic cancer, Elderly, Palliative care, ChemotherapyAbstract
Pancreatic cancer is responsible for a significant disease burden on the aging US population. The only chance at curing this highly morbid disease is surgical resection, however choosing appropriate surgical candidates in the elderly population remains challenging. We review the literature for appropriate treatment modalities to the elderly patient. Although significant literature exists in choosing appropriate surgical candidates as well as managing those not deemed fit for surgery, the medical community is not unified when approaching these patients. Further collaboration between the surgical, medical, and palliative communities will likely spawn better outcomes for less overall health care cost in the future.
References
Yeo TP, Lowenfels AB. Demographics and epidemiology of pancreatic cancer. Cancer J. 2012; 18(6): 477-484. doi: 10.1097/ PPO.0b013e3182756803
Surveillance Epidemiology and End Results. SEER Fact Sheets: Pancreas. Web site. http://seer.cancer.gov/. Accessed July 15, 2016.
Huisman MG, Audisio RA, Ugolini G, et al. Screening for predictors of adverse outcome in onco-geriatric surgical pa-tients: A multicenter prospective cohort study. Eur J Surg Oncol. 2015; 41(7): 844-851. doi: 10.1016/j.ejso.2015.02.018
Tran Ba Loc P, du Montcel ST, Duron JJ, et al. Elderly POS-SUM, a dedicated score for prediction of mortality and morbid-ity after major colorectal surgery in older patients. Br J Surg. 2010; 97(3): 396-403. doi: 10.1002/bjs.6903
Turrentine FE, Wang H, Simpson VB, Jones RS. Surgi-cal risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006; 203(6): 865-877. doi: 10.1016/j.jamcoll-surg.2006.08.026
Hamel MB, Henderson WG, Khuri SF, Daley J. Surgical out-comes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery. J Am Geriatr Soc. 2005; 53(3): 424-429. doi: 10.1111/j.1532-5415.2005.53159.x
McNicol L, Story DA, Leslie K, et al. Postoperative com-plications and mortality in older patients having non-cardiac surgery at three Melbourne teaching hospitals. Med J Aust. 2007; 186(9): 447-452. Web site. https://www.mja.com.au/jour-nal/2007/186/9/postoperative-complications-and-mortality-old-er-patients-having-non-cardiac. Accessed July 14, 2016
Bilimoria KY, Mentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early state pan-creatic cancer. Ann Surg. 2007; 246(2): 173-180. doi: 10.1097/ SLA.0b013e3180691579
Lawrence VA, Hazuda HP, Cornell JE, et al. Functional in-dependence after major abdominal surgery in the elderly. J Am Coll Surg. 2004; 199(5): 762-772. doi: 10.1016/j.jamcoll-surg.2004.05.280
Lightner AM, Glasgow RE, Jordan TH, et al. Pancreatic re-section in the elderly. J Am Coll Surg. 2004; 198(5): 697-706. doi: 10.1016/j.jamcollsurg.2003.12.023
Deiner S, Silverstein JH. Postoperative delirium and cogni-tive dysfunction. Br J Anaesth. 2009; 103(Suppl 1): i41-i46. doi: 10.1093/bja/aep291
Abildstrom H, Rasmussen LS, Rentowl P, et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cogni-tive Dysfunction. Acta Anaesthesiol Scand. 2000; 44(10): 1246- 1251. doi: 10.1034/j.1399-6576.2000.441010.x
Ferfuson G. Pancreatico-duodenectomy: Operation on two elderly patients. Br Med J. 1954.
Bathe OF, Levi D, Caldera H, et al. Radical resection of periampullary tumors in the elderly: Evaluation of long-term results. World J Surg. 2000; 24(3): 353-358. doi: 10.1007/ s002689910056
Hodul P, Tansey J, Golts E, et al. Age is not a contraindica-tion to pancreaticoduodenectomy. Am Surg. 2001; 67(3): 270- 275. Web site. http://search.proquest.com/openview/878ad5e8 812d22375068082eb6aae539/1?pq-origsite=gscholar. Accessed July 15, 2016
Brozzetti S, Mazzoni G, Miccini M, et al. Surgical treatment of pancreatic head carcinoma in elderly patients. Arch Surg. 2006; 141(2): 137-142. doi: 10.1001/archsurg.141.2.137
Makary MA, Winter JM, Cameron JL, et al. Pancreaticoduo-denectomy in the very elderly. J Gastrointest Surg. 2006; 10(3): 347-356. doi: 10.1016/j.gassur.2005.12.014
Scurtu R, Bachellier P, Oussoultzoglou E, Rosso E, Maroni R, Jaeck D. Outcome after pancreaticoduodenectomy for cancer in elderly patients. Gastrointest Surg. 2006; 10(6): 813-822. doi: 10.1016/j.gassur.2005.12.010
Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenar-ians undergoing high-risk cancer operation: A national study. J Am Coll Surg. 2007; 205(6): 729-734. doi: 10.1016/j.jamcoll-surg.2007.06.307
Riall TS, Reddy DM, Nealon WH, Goodwin JS. The ef-fect of age on short-term outcomes after pancreatic resection: A population-based study. Ann Surg. 2008; 248(3): 459-467. doi: 10.1097/SLA.0b013e318185e1b3
Ito Y, Kenmochi T, Irino T, et al. The impact of surgical out-come after pancreaticoduodenectomy in elderly patients. World J Surg Oncol. 2011; 9: 102. doi: 10.1186/1477-7819-9-102
Oguro S, Shimada K, Kishi Y, et al. Perioperative and long-term outcomes after pancreaticoduodenectomy in elderly pa-tients 80 years of age and older. Langenbecks Arch Surg. 2013; 398(4): 531-538. doi: 10.1007/s00423-013-1072-7
Frakes JM, Strom T, Springett GM, et al. Resected pancre-atic cancer outcomes in the elderly. J Geriatr Oncol. 2015; 6(2): 127-132. doi: 10.1016/j.jgo.2014.11.005
Zhang D, Gao J, Li S, et al. Outcome after pancreaticoduode-nectomy for malignancy in elderly patients. Hepatogastroenter-ology. 2015; 62(138): 451-454. Web site. http://europepmc.org/ abstract/med/25916080. Accessed July 14, 2016
Robinson TN, Wu DS, Pointer L, Dunn CL, Cleveland JC Jr, Moss M. Simple frailty score predicts postoperative complica-tions across surgical specialties. Am J Surg. 2013; 206(4): 544- 550. doi: 10.1016/j.amjsurg.2013.03.012
Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a pre-dictor of surgical outcomes in older patients. J Am Coll Surg. 2010; 210(6): 901-908. doi: 10.1016/j.jamcollsurg.2010.01.028
Podsiadlo D, Richardson S. The timed “Up & Go”: A test of basic functional mobility for frail elderly persons. J Am Geri-atr Soc. 1991; 39(2): 142-148. doi: 10.1111/j.1532-5415.1991. tb01616.x
Soubeyran P, Fonck M, Blanc-Bisson C, et al. Predictors of early death risk in older patients treated with first-line chemo-therapy for cancer. J Clin Oncol. 2012; 30(15): 1829-1834. doi: 10.1200/JCO.2011.35.7442
Audisio RA, Pope D, Ramesh HS, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008; 65(2): 156-163. doi: 10.1016/j.critrev-onc.2007.11.001
Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014; 32(24): 2595-2603. doi: 10.1200/JCO.2013.54.8347
Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric as-sessment in older cancer patients: An update on SIOG recom-mendations. Ann Oncol. 2015; 26(2): 288-300. doi: 10.1093/ annonc/mdu210
Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: Delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015; 16(11): 1193-1224. doi: 10.1016/S1470- 2045(15)00223-5
Dale W, Hemmerich J, Kamm A, et al. Geriatric assess-ment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: A prospective co-hort study. Ann Surg. 2014; 259(5): 960-965. doi: 10.1097/ SLA.0000000000000226
Amano K, Maeda I, Shimoyama S, et al. The accuracy of physicians’ clinical predictions of survival in patients with ad-vanced cancer. J Pain Symptom Manage. 2015; 50(2): 139-146. doi: 10.1016/j.jpainsymman.2015.03.004
Jang RW, Krzyzanowska MK, Zimmermann C, Taback N, Alibhai SMH. Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. J Natl Cancer Inst. 2015; 107(3): pii: dju424. doi: 10.1093/jnci/dju424
Ljungman D, Hyltander A, Lundholm K. Cost-utility esti-mations of palliative care in patients with pancreatic adenocar-cinoma: A retrospective analysis. World J Surg. 2013; 37(8): 1883-1891. doi: 10.1007/s00268-013-2003-z
National Comprehensive Cancer Network (NCCN). 2015. http://www.nccn.org/professionals/physician_gls/pdf/pancre-atic.pdf
Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX ver-sus ge38. mcitabine for metastatic pancreatic cancer. N Engl J Med. 2011; 364: 1817-1825. doi: 10.1056/NEJMoa1011923
Gurusamy KS, Kumar S, Davidson BR, et al. Resection versus other treatments for locally advanced pancreatic can-cer. Cochrane Database Syst Rev. 2014; 2: CD010244. doi: 10.1002/14651858.CD010244.pub2
Maréchal R, Demols A, Gay F, et al. Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly pa-tients with advanced pancreatic cancer. Pancreas. 2008; 36(3): e16-e21. doi: 10.1097/MPA.0b013e31815f3920
Locher C, Fabre-Guillevin E, Brunetti F, et al. Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: An observational study. Crit Rev Oncol Hematol. 2008; 68(2): 178-182. doi: 10.1016/j.critrevonc.2008.06.010
Yamagishi Y, Higuchi H, Izumiya M. Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancre-atic carcinoma. J Gastroenterol. 2010; 45(11): 1146-1154. doi: 10.1007/s00535-010-0258-9
Matsumoto K, Miyake Y, Kato H, et al. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly pa-tients. Digestion. 2011; 84(3): 230-235. doi: 10.1159/000330384
Hentic O, Dreyer C, Rebours V, et al. Gemcitabine in elderly patients with advanced pancreatic cancer. World J Gastroen-terol. 2011; 17(30): 3497-3502. doi: 10.3748/wjg.v17.i30.3497
Berger AK, Abel U, Komander C, et al. Chemotherapy for advanced pancreatic adenocarcinoma in elderly patients (≥70 years of age): A retrospective cohort study at the National Cen-ter for Tumor Diseases Heidelberg. Pancreatology. 2014; 14(3): 211-215. doi: 10.1016/j.pan.2014.03.004
Oziel-Taieb S, Faure M, Gilabert M, et al. Treatment of pan-creatic adenocarcinoma in elderly patients over 75 years of age: A retrospective series of 129 patients. J Gastrointest Cancer. 2015; 47(1): 15-19. doi: 10.1007/s12029-015-9774-4
Kneuertz PJ, Cunningham SC, Cameron JL, et al. Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: Trends and lessons learned from a large, single institution experience. J Gastrointest Surg. 2011; 15(11): 1917- 1927. doi: 10.1007/s11605-011-1665-9
Glazer ES, Hornbrook MC, Krouse RS. A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction. J Pain Symptom Manage. 2014; 47(2): 307-314. doi: 10.1016/j. jpainsymman.2013.03.013
Moss AC, Morris E, MacMathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 2006; (1): CD004200. doi: 10.1002/14651858.CD004200. pub2
Hwang SI, Kim HO, Son BH, et al. Surgical palliation of unresectable pancreatic head cancer in elderly patients. World J Gastroenterol. 2009; 15(8): 978-982. doi: 10.3748/wjg.15.978
van Hooft JE, Dijkgraaf MG, Timmer R, et al. Independent predictors of survival in patients with incurable malignant gas-tric outlet obstruction: A multicenter prospective observational study. Scand J Gastroenterol. 2010; 45(10): 1217-1222. doi: 10.3109/00365521.2010.487916
Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. en-doscopic stenting. A randomized prospective trial. Anticancer Res. 2004; 24(1): 269-271.
Mehta S, Hindmarsh A, Cheong E, et al. Prospective ran-domized trial of laparoscopic gastrojejunostomy versus duo-denal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006; 20(2): 239-242. doi: 10.1007/s00464-005-0130-9
Jeurnink SM, Steyerberg EW, van Hooft JE, et al. Surgical gastrojejunostomy or endoscopic stent placement for the pallia-tion of malignant gastric outlet obstruction (SUSTENT study): A multicenter randomized trial. Gastrointest Endosc. 2010; 71(3): 490-499. doi: 10.1016/j.gie.2009.09.042
Mansoor H, Zeb F. Enteral stents are safe and effective to relieve malignant gastric outlet obstruction in the elderly. J Gas-trointest Cancer. 2015; 46(1): 42-47. doi: 10.1007/s12029-014- 9675-y
Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduo-denectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996; 223(6): 718-725. Web site. http://www. ncbi.nlm.nih.gov/pmc/articles/PMC1235219/. Accessed July 15, 2016
Schniewind B, Bestmann B, Kurdow R, et al. Bypass sur-gery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Ann Surg Oncol. 2006; 13(11): 1403-1411. doi: 10.1245/s10434-006-9172-z
Tol JA, Eshuis WJ, Besselink MG, et al. Non-radical resec-tion versus bypass procedure for pancreatic cancer - a consecu-tive series and systematic review. Eur J Surg Oncol. 2015; 41(2): 220-227. doi: 10.1016/j.ejso.2014.11.041
Martin RC, McFarland K, Ellis S, et al. Irreversible elec-troporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol. 2013; 20(Suppl 3): S443-S449. doi: 10.1245/s10434-012-2736-1
Narayanan G, Hosein PJ, Arora G, et al. Percutaneous ir-reversible electroporation for downstaging and control of unre-sectable pancreatic adenocarcinoma. J Vasc Interv Radiol. 2012; 23(12): 1613-1621. doi: 10.1016/j.jvir.2012.09.012
Månsson C, Bergenfeldt M, Brahmstaedt R, et al. Safety and preliminary efficacy of ultrasound-guided percutaneous ir-reversible electroporation for treatment of localized pancreatic cancer. Anticancer Res. 2014; 34(1): 289-293. Web site. http:// ar.iiarjournals.org/content/34/1/289.long. Accessed July 15, 2016.
Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchnicectomy in patients with unresectable pancreatic can-cer. A prospective randomized trial. Ann Surg. 1993; 217(5): 447-455. Web site. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC1242819/. Accessed July 15, 2016.
Okuyama M, Shibata T, Morita T, et al. A comparison of intraoperative celiac plexus block with pharmacological therapy as a treatment for pain of unresectable pancreatic cancer. J Hep-atobiliary Pancreat Surg. 2002; 9(3): 372-375. doi: 10.1007/ s005340200042
Wong GY, Schroeder DR, Carns PE, et al. Effect of neurolyt-ic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004; 291(9): 1092-1029. doi: 10.1001/ jama.291.9.1092
Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Data-base Syst Rev. 2011; (3): CD007519. doi: 10.1002/14651858. CD007519.pub2
Langan R, Huang C, Mao W, et al. Pancreaticoduodenec-tomy hospital resource utilization in octogenarians. Am J Surg. 2016; 211(1): 70-75. doi: 10.1016/j.amjsurg.2015.04.014
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Surgical Research (SR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.